Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Grippol Quadri vs Grippol Plus in Healthy Adults
NCT03849560Phase 3Completed
- Sponsor
- Petrovax Pharm
- Start
- Nov 2016
- Primary completion
- Jun 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Grippol Quadrivalent in influenza, sponsored by Petrovax Pharm. Started Nov 2016; status: completed.
02
Drugs
Grippol Quadrivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03849560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03849560.